Table 2.
The incidence and severity of arthritis after intra-articular injection of 100 µg peptidoglycan to SCID mice depleted of neutrophils and monocytes
| Number | |||
| Group | of mice | Incidence (%) | Severity |
| CB17 | 10 | 100 | 2.8 ± 0.4 |
| SCID + RB6-8C5 | 10 | 100 | 1.6 ± 0.5 |
| SCID +etoposide | 8 | 50 | 0.5 ± 0.5 |
| SCID+ RB6-8C5 + | 8 | 50 | 0.6 ± 0.7 |
| etoposide | |||
| BALB/c+RB6-8C5 + | 10 | 70 | 1.5 ± 1.1 |
| etoposide |